Breakthrough in Dravet Syndrome Gene Therapy Recent research has introduced a promising gene replacement therapy for Dravet...
Pharmaceuticals
Introduction In a strategic move to enhance its obesity treatment portfolio, Novo Nordisk has entered into a...
LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year...
